AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT02526121 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Dietary and lifestyle counseling.
Description: Dietary and lifestyle counseling.
Study NCT04527107 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: THR-149 dose level 1
Description: 3 intravitreal injections of THR-149 dose level 1, 1 month apart
Study NCT04527107 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: THR-149 dose level 2
Description: 3 intravitreal injections of THR-149 dose level 2, 1 month apart
Study NCT04527107 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: THR-149 dose level 3
Description: 3 intravitreal injections of THR-149 dose level 3, 1 month apart
Study NCT04527107 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: THR-149 0.13mg
Description: 3 intravitreal injections of THR-149 0.13mg (selected dose level), 1 month apart, followed after 1 month by a sham (pretend) injection
Study NCT04527107 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: THR-149 0.13mg + aflibercept 2mg
Description: 3 intravitreal injections of THR-149 0.13mg (selected dose level), 1 month apart, followed after 1 month by an intravitreal injection of aflibercept 2mg
Study NCT04527107 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: aflibercept 2mg + THR-149 0.13mg
Description: 3 intravitreal injections of aflibercept 2mg, 1 month apart, followed after 1 month by an intravitreal injection of THR-149 0.13mg (selected dose level)
Study NCT04527107 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Aflibercept 2mg
Description: 3 intravitreal injections of aflibercept 2mg, 1 month apart, followed after 1 month by a sham (pretend) injection
Study NCT01566617 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Standard care and Pharmaceutical care
Description: Pharmaceutical care is the direct interaction between the pharmacist and the drug's users in order to improve the therapeutic compliance among outpatients and promote adequate pharmacotherapeutic follow-up.
Study NCT01566617 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Standard care
Description: These patients will only receive standard care, with out follow-up by the pharmacist
Study NCT01416753 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: UCR
Description: BVM-based regulation of ultrafiltration and conductivity
Study NCT01416753 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: UTR
Description: BVM-based regulation of ultrafiltration; regulation of temperature
Study NCT00321412 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: AST-120
Description: oral, sachet, 2 grams three times daily for 8 weeks
Study NCT02836821 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Apatinib Mesylate Tablets
Description: apatinib was administered in the morning after an overnight fast of at least 10 h
Study NCT02836821 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rifampicin Capsules
Description: rifampicin was administered in the morning 2 hours after breakfast
Study NCT04776226 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Citalopram
Description: Antidepressant use in patients with depression
Study NCT02107456 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Dry Needling
Description: Dry needling was performed for one week, three times a week.
Study NCT01767363 — intervention group
Intervention type: OTHER
Intervention: 5-alpha reductase inhibitors
Description: Use of 5-alpha reductase inhibitors over the course of the study period.
Study NCT01767363 — intervention group
Intervention type: OTHER
Intervention: Alpha-blockers
Description: Use of alpha-blockers over the study period.
Study NCT03965286 — intervention group
Intervention type: DRUG
Intervention: DAAs
Description: Daily fixed-dose combination of ledipasvir (90 mg)/sofosbuvir (400 mg) 12 weeks Daily simeprevir (150 mg) plus sofosbuvir (400 mg) 12 weeks Daily daclatasvir (60 mg) plus sofosbuvir (400 mg) 12 weeks Daily fixed-dose combination of paritaprevir (150 mg)/ritonavir (100 mg)/ombitasvir (25 mg) with dasabuvir (600 mg) 12weeks
Study NCT05457231 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: specific feedback based on an in-depth assessment tool for communication skills training
Description: In addition to the specific feedback based on an in-depth assessment tool, four strategies modified from common strategies in the previous studies were incorporated into the intervention protocol, including lecture, patient interview, brief feedback, and self-reflection
Study NCT06354894 — intervention group
Intervention type: DEVICE
Intervention: Proximal humeral fracture fixation
Description: percutaneous pinning VS plate and screws
Study NCT03696745 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: autologous umbilical cord blood stem cells
Description: autologous umbilical cord blood stem cells treatment for brain injury for safety and effect evaluation
Study NCT03696745 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: 0.9% Sodium-chloride
Description: 0.9% Sodium-chloride in control group
Study NCT01247701 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Busulfan
Description: Busulfan dosing will be as follows: Patients \< 12 kg: 1.1 mg/kg/dose IV every 6 hours for 16 doses total; patients > 12 kg: 0.8 mg/kg/dose IV every 6 hours for 16 doses. It will be given on Days -9, -8, -7 and -6.
Study NCT01247701 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cyclophosphamide
Description: Cyclophosphamide (50 mg/kg/dose) will be given IV on Days -5, - 4, -3, and -2 over 1 hour. The total dose to be given over 4 days is 200 mg/kg.
Study NCT01247701 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fludarabine
Description: Fludarabine will be given IV daily over 1 hour for 3 days. Dosing will be as follows: for patients ≤ 10 kg: 1.3 mg/kg; for patients > 10 kg: 40 mg/m\^2.
Study NCT01247701 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Cord Blood Stem Cell Infusion
Description: The cord blood stem cells will be infused on Day 0.
Study NCT03987191 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Multiple daily ijnection using Insulin Degludec and Insulin Aspart
Description: Drug: Insulin Degludec and insulin Aspart Pharmaceutical form: Solution for injection Route of administration: Subcutaneous
Study NCT02219113 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Intraarticular administration of autologous ADRC
Study NCT03774498 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Sensodyne repair and protect
Description: NovaMin \& fluoride toothpaste
Study NCT03987191 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Multiple daily ijnection using Insulin Degludec and Insulin Aspart
Description: Drug: Insulin Degludec and insulin Aspart Pharmaceutical form: Solution for injection Route of administration: Subcutaneous
Study NCT03789994 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Affective touch
Description: The affective touch comprises of two elements, namely the signal of care, love and acceptance, and stimulation of CT afferent of the skin. Caregivers will be trained to perform light stroking on stroke survivor's forearm while reviewing happy events with the use of photos.
Study NCT03789994 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Fine motor exercise
Description: Fine motor exercises that are commonly used for rehabilitation.
Study NCT06187363 — intervention group
Intervention type: PROCEDURE
Intervention: Tubularized incised plate procedure
Description: Tubularized incised plate urethroplasty procedure
Study NCT06187363 — intervention group
Intervention type: PROCEDURE
Intervention: Other procedures
Description: Other procedures than tubularized incised plate urethroplasty procedure
Study NCT03832088 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Berg Balance Scale
Description: Berg Balance Scale performed for balance disorder
Study NCT03832088 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Timed Up and Go Test
Description: Timed Up and Go Test for walking speed
Study NCT00834431 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Famciclovir 500 mg Tablets
Description: 1 x 500 mg, single-dose fasting
Study NCT00834431 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Famvir® 500 mg Tablets
Description: 1 x 500 mg, single-dose fasting
Study NCT04033276 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Rituximab
Description: IV rituximab
Study NCT04033276 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: intravenous immune globulin
Description: iv intravenous immune globulin
Study NCT02732821 — intervention group
Intervention type: PROCEDURE
Intervention: Gastric Per Oral Endoscopic Myotomy
Description: Patients will receive Per Oral Endoscopic Gastric Myotomy for Gastroparesis.
Study NCT03934476 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Ketogenic diet
Description: The study subjects randomized for this intervention will observe the ketogenic diet, as prescribed by the protocol.
Study NCT03934476 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Exercise HIIT
Description: The study subjects randomized for this intervention will observe the HIIT exercise programme, as prescribed by the protocol.
Study NCT04062955 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Questionnaire Administration
Description: Ancillary studies
Study NCT02466256 — intervention group
Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: Intraocular lens implantation
Description: Intraocular lens implantation
Study NCT02466256 — intervention group
Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: Autosert Injector
Description: Motorised injection device for intraocular lens implantation
Study NCT02466256 — intervention group
Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: Royale Injector
Description: Manual, plunger type injection device for intraocular lens implantation
Study NCT02466256 — intervention group
Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: Monarch III Injector
Description: Manual, screw type injection device for intraocular lens implantation
Study NCT02795234 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Blood samples
Study NCT01154101 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Placebo
Description: For the placebo product, the SRT2104 drug substance will be replaced by microcrystalline cellulose (Avicel® PH 105) to match the SRT2104 investigational product.
Study NCT01613872 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Mindfulness Based Stress Reduction
Description: An 8 week protocol of stress reduction sessions using gentle yoga and breath meditation
Study NCT03238183 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: dextrose
Description: compare the therapeutic effects of hyaluronic acid combined dextrose injections with hyaluronic acid injections only to patients with knee osteoarthritis
Study NCT03238183 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: hyaluronic acid
Description: compare the therapeutic effects of hyaluronic acid combined dextrose injections with hyaluronic acid injections only to patients with knee osteoarthritis
Study NCT01154101 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: SRT2104
Description: SRT2104 drug substance is a new chemical entity which is supplied as a fine, yellowish/amber powder. The SRT2104 investigational product is prepared by packing 250 mg of micronized SRT2104 powder with no additional additives into a size 00 opaque, hard gelatin capsule, packaged in dosing bottles containing a single daily dose.
Study NCT00215150 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Ziprasidone
Description: Sertraline augmentation with ziprasidone
Study NCT00215150 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Sertraline
Description: Treatment by sertraline in open label phase, followed by ziprasidone/placebo randomized augmentation in the randomized phase
Study NCT03832088 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Jamar hand dynamometer
Description: Jamar hand dynamometer for grip strength which correlates with muscle strength of patient
Study NCT03238183 — intervention group
Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: hyaluronic acid
Description: compare the therapeutic effects of hyaluronic acid combined dextrose injections with hyaluronic acid injections only to patients with knee osteoarthritis
Study NCT00263588 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: lapatinib
Description: tyrosine kinase inhibitor
Study NCT01403194 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: CPAP/BiPAP
Description: Subjects will be treated with either CPAP or Bi-PAP for three months.
Study NCT04407403 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Tai Chi tailored for lowering blood pressure (PRESSURE)
Description: PRESSURE Tai Chi routine consisted of eight forms following Yang style. PRESSURE was tailored for the targeted health outcome of BP in consultation with the professional, certified Tai Chi instructor and an experienced physical therapist. Specifically, investigators tailored PRESSURE to emphasize slow, deep breathing and relaxation by utilizing Tai Chi movements that: 1) were slow and smooth; 2) without break or pause; and 3) had minimal muscular force and exertion. Investigators included the following eight forms in PRESSURE: 1) Begin Tai Ji Quan; 2) Part the Horse's Mane; 3) Brush Knee and Push; 4) Cloud Hands; 5) Open and Close; 6) Part the Grass; 7) Single Whip; and 8) Finish Tai Ji Quan.
Study NCT04407403 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Tai Chi tailored for improving balance (BALANCE)
Description: BALANCE Tai Chi routine consisted of eight forms following Yang style. BALANCE was tailored for the targeted health outcome of balance in consultation with the professional, certified Tai Chi instructor and an experienced physical therapist. Specifically, investigators tailored BALANCE to provide moderate to high levels of challenge to balance control by emphasizing movement principles (e.g., consciously control weight shifting during multi-directional stepping), and integrating Tai Chi movements that: 1) reduced the base of support; 2) moved the center of gravity; and 3) improved lower-extremity strength. Investigators included the following eight forms in BALANCE: 1) Begin Tai Ji Quan; 2) Roll the Ball; 3) Kick with Heel; 4) Repulse the Monkey; 5) Gather the Earth's Qi; 6) White Crane Spread Wing; 7) Fairy Weaves the Shuttle; and 8) Finish Tai Ji Quan.
Study NCT01931553 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Standardized attending morning rounds
Study NCT01771263 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: iControl-RP
Study NCT02310386 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: BEMER electromagnetic field therapy
Description: To study the effects of three months electromagnetic field therapy on pain in women with fibromyalgia.
Study NCT03832088 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Calf circumference
Description: Calf circumference for muscle mass evaluation. Calf circumference is an anthropometric measurement which correlates with muscle mass.
Study NCT00971503 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: autologous bone marrow implantation
Description: Filgrastim treatment before bone marrow aspiration that will then be implanted via pancreatic artery
Study NCT00971503 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Saline injection
Description: Injection of saline solution for 5 days
Study NCT03339453 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nasal Glucagon
Description: Administered nasally
Study NCT03339453 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Intramuscular Glucagon
Description: Administered IM
Study NCT03802357 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Exercise training
Description: Patients perform an exercise Training program of 3 weeks Duration including endurance Training, resistance Training and squat Training. This program is part of an inpatient pulmonary Rehabilitation.
Study NCT03802357 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Exercise training
Description: Patients perform an exercise Training program of 3 weeks Duration including endurance Training, resistance Training and squat Training. This program is part of an inpatient pulmonary Rehabilitation.
Study NCT02480361 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: acupuncture
Description: Acupuncture treatment after gastric cancer surgery during 5 postoperative days
Study NCT03123107 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ascorbic Acid
Description: Ascorbic acid doses will be mixed in 100 mL normal saline and infused over 60 minutes. The postoperative dose will be given on postoperative day #1.
Study NCT04503980 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: αPD1-MSLN-CAR T cells
Description: Subjects will undergo leukapheresis to isolate peripheral blood mononuclear cells (PBMCs) for the production of αPD1-MSLN-CAR T cells. During αPD1-MSLN-CAR T cells production, subjects will receive cyclophosphamide for the purpose of lymphocytes depletion. After lymphodepletion, subjects will receive one dose treatment with αPD1-MSLN-CAR T cells by intravenous (IV) injection. The initial dose of 1×10\^5 CAR+ T cells/kg will be infused on day 0.
Study NCT02310386 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: BEMER electromagnetic field therapy
Description: To study the effects of three months electromagnetic field therapy on pain in women with fibromyalgia.
Study NCT04413266 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Curcumin supplementation
Description: The patients will receive 3 capsules per day containing 500mg of curcumin for 4 weeks
Study NCT04413266 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Curcumin supplementation
Description: The patients will receive 3 capsules per day containing 500mg of curcumin for 4 weeks
Study NCT04178590 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SRP + Injectable Platelet-Rich Fibrin
Description: Injectable Platelet-Rich Fibrin application as adjunct to scaling and root planing
Study NCT04178590 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: SRP + placebo
Description: Saline application during scaling and root planing
Study NCT03665597 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Pembrolizumab Dose C
Description: SC injection
Study NCT01117220 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo matching the oral ziprasidone capsules of 20,40, 60 and 80 mg in strength. Subjects will be dosed for 4 weeks using a flexible dose design with minimal dose range of 40 mg twice a day (BID) to maximum dose range of 80 mg BID (weight specific- \< 45kg max dose 40 mg BID).
Study NCT01117220 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ziprasidone Oral Capsules
Description: Oral ziprasidone capsules of 20,40, 60 and 80 mg in strength. Subjects will be dosed for 4 weeks using a flexible dose design with minimal dose range of 40 mg twice a day (BID to maximum dose range of 80 mg BID (weight specific- \< 45kg max dose 40 mg BID).
Study NCT05394935 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: High-Intensity Exercise
Description: Acute, low-volume HIIT 12x (1min:1min) Working intensity: >85% heart rate reserve Resting intensity: Active rest
Study NCT05394935 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: High-Intensity Exercise
Description: Acute, low-volume HIIT 12x (1min:1min) Working intensity: >85% heart rate reserve Resting intensity: Active rest
Study NCT05394935 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Moderate-Intensity Exercise
Description: Continuous, MISS 50mins Working intensity: 50-60% heart rate reserve
Study NCT05394935 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Moderate-Intensity Exercise
Description: Continuous, MISS 50mins Working intensity: 50-60% heart rate reserve
Study NCT03992118 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Parent coaching
Description: Parents will be coached to implement behavioural strategies to address factors which are contributing to difficult mealtime behaviours and feeding challenges.
Study NCT02416271 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Teriparatide
Description: Administered SC
Study NCT02760732 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: drug eluting balloon; cutting balloon
Description: Patients eligible for inclusion criteria were randomised to study group for percutaneous transluminal coronary angioplasty with a strategy of cutting balloon pre-dilation first and then drug eluting balloon.
Study NCT02760732 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: drug eluting stent
Description: with a strategy of drug-eluting stent implantation alone for de novo coronary artery lesions.
Study NCT01859858 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: curcumin
Study NCT01859858 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Irinotecan